Motion of Wyeth on Fen Phen Primary Pulmonary Hypertension Lawsuit Denied: Now, AttorneyOne Can Provide Advice

According to court documents, on January 16th, 2013, US District Judge signed the pretrial order that the motion of Wyeth on Fen Phen primary pulmonary hypertension lawsuit is denied. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fen Phen side effects. http://www.attorneyone.com/fen-phen-lawsuits/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fen Phen: serious adverse events

Fen Phen: serious adverse events

plaintiff claims she suffers from primary pulmonary hypertension as a result of ingesting Wyeth’s diet drugs known as Fenfluramine and Phentermine

San Diego, CA (PRWEB) February 26, 2013

AttorneyOne.com, a recognized authority on law, informs on the latest news concerning Fen Phen lawsuits.

According to court documents, on January 16th, 2013, US District Judge signed the pretrial order that the motion of Wyeth on Fen Phen primary pulmonary hypertension lawsuit is denied (Pennsylvania Eastern District Court, Case No. 2:2012cv20010). Fen Phen, a popular Wyeth obesity drug, was withdrawn from the market in 1997 as it was linked with heart valve damage and primary pulmonary hypertension (PPH). The lawsuit has been transfereed to the Fen Phen Multidistrict Litigation - IN RE: Diet Drugs (Phentermine/ Fenfluramine/ Dexfenfluramine) Products Liability Litigation, No. 1203. In the lawsuit, plaintiff claims she suffers from primary pulmonary hypertension as a result of ingesting Wyeth’s diet drugs known as Fenfluramine and Phentermine.

According to the US Judicial Panel on Multidistrict Litigation (MDL) there are currently 100 actions pending in the Fen Phen MDL, as of January 14th, 2013.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Fen Phen severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Fen Phen lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On September 27th, 2012, a lawsuit filed in Delaware District Court (case no. 1:2012cv00906), alleging primary pulmonary hypertension from fenfluramine and phentermine, was transferred to the Fen Phen Multidistrict Litigation.

As mentioned in the 2008 research article, published in BMC Medicine, fenfluramine-induced valve disease requiring surgery was identified seven years after discontinuing the medication.

AttorneyOne.com has further information on Fen Phen lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/2/prweb10452009.htm